Iron metabolism disorders, including iron overloads, are characterized by important phenotypic expression variabilities for similar etiologies. The mechanisms involved are not fully identified. Interrelations between iron and other metals may contribute to this variability. The aim of this work, performed in mouse, was to investigate interactions between iron and other metals metabolisms. We have: i) shown that mice genetic background modulates other metals metabolism, besides iron; and ii) identified links between parameters of these metals in physiological condition. We have also highlighted, in mice models of iron overload, related either to exogenous iron exposure, or to deficiency in hepcidin (the systemic iron metabolism regulator), a strong link between iron metabolism and molybdenum and manganese metabolisms, particularly in spleen. These results suggest that regulatory mechanisms, possibly involving directly or indirectly the hepcidin / ferroportin axis, may be shared by iron, molybdenum and manganese. The clarification of hepcidin role needs further investigations. In vivo dynamic explorations with stable isotopes being a possible approach to better understand mechanisms of iron metabolism control, we have characterized the distribution of iron stable isotopes (using 56Fe/54Fe isotope ratio) in tissues involved in its metabolism. We have confirmed the variation of 56Fe/54Fe isotope ratio between organs, and highlighted a different iron isotope fractionation in liver according to mice genetic backgrounds. These results show the importance to take into account this essential feature for metabolic studies aspiring to better understand iron metabolism and its links with other metals metabolism, in physiological or pathological conditions.